Published online Feb 26, 2022. doi: 10.12998/wjcc.v10.i6.1806
Peer-review started: November 24, 2021
First decision: December 9, 2021
Revised: January 4, 2022
Accepted: January 17, 2022
Article in press: January 17, 2022
Published online: February 26, 2022
Processing time: 91 Days and 6.1 Hours
The efficacy of transcatheter aortic valve implantation (TAVI) and prognosis of aortic stenosis (AS) is usually restricted by perioperative adverse events. Global longitudinal strain is a commonly used echocardiographic parameter for the detection of left ventricular function. Whether there is an association between the changes in global longitudinal strain and the occurrence of perioperative adverse events during TAVI remains unknow.
If global longitudinal strain is useful for the predication of perioperative adverse events, monitoring of global longitudinal strain can be carried out before the operation and corresponding measures can be taken to reduce the operational risk.
To assess changes in left ventricular global longitudinal strain (LVGLS) during the surgery of TAVI and the association between LVGLS and perioperative adverse events in patients with calcified aortic stenosis.
A retrospective study was carried in 61 patients with calcified AS undergoing TAVI. These patients underwent standard echocardiography examination. LVEF and LVGLS data were collected during preoperative balloon expansion, preoperative stent implantation, and balloon expansion-stent implantation. The patients were categorized into a normal left ventricular ejection fraction (LVEF) group and a reduced LVEF group, and the normal LVEF group was further stratified into a normal LVGLS subgroup and an increased LVGLS subgroup. The association between changes in LVEF and LVGLS and the occurrence of perioperative adverse events were analyzed.
In the preserved LVEF group, LVEF only showed obvious change in preoperative balloon expansion section, while LVGLS declined significantly in both preoperative balloon expansion and preoperative stent implantation sections. In the decreased LVEF group, neither LVEF nor LVGLS displayed significant changes. Changes in LVGLS in preoperative balloon expansion section and preoperative stent implantation section were associated with perioperative adverse events which indicating changes in LVGLS during TAVI may have an influence on the occurrence of perioperative adverse events.
In the preserved LVEF group, changes in LVGLS were greater than in LVEF. LVGLS can be a marker to be used for the prediction of changes in cardiac function during TAVI.
The optimal cut-off value for LVGLS and timing for measurement of LVGLS still needs to be guaranteed by large scale multi-center studies.